PTC Therapeutics's total assets for Q2 2025 were $2.63B, a decrease of -0.80% from the previous quarter. PTCT total liabilities were $2.84B for the fiscal quarter, a -0.02% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.